Xerecept

DRUG2 trials

Sponsors

PharmaNet, Celtic Pharma Development Services

Conditions

Brain EdemaBrain TumorPRIMARY MALIGNANT and METASTATIC BRAIN TUMORSPeritumoral Brain Edema

Phase 1

Tolerability Study of Xerecept® in Pediatric Patients

TerminatedNCT01369121

Celtic Pharma Development ServicesBrain Edema, Brain Tumor

Start: 2010-06-30End: 2013-03-31Updated: 2013-07-30

Phase 2

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

TerminatedNCT00691522

PharmaNetPeritumoral Brain Edema, PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS

Start: 2008-11-30End: 2009-10-31Target: 60Updated: 2009-01-09